.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Daiichi Sankyo
Chubb
QuintilesIMS
Julphar
Queensland Health
Healthtrust
Medtronic
UBS
Moodys

Generated: June 26, 2017

DrugPatentWatch Database Preview

DIMENHYDRINATE Drug Profile

« Back to Dashboard

Which patents cover Dimenhydrinate, and when can generic versions of Dimenhydrinate launch?

Dimenhydrinate is a drug marketed by Watson Labs Teva, Alra, Wyeth Ayerst, Fresenius Kabi Usa, Watson Labs, Heather, Baxter Hlthcare, and Nexgen Pharma Inc. and is included in nine NDAs.

The generic ingredient in DIMENHYDRINATE is dimenhydrinate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dimenhydrinate profile page.

Summary for Tradename: DIMENHYDRINATE

Patents:0
Applicants:8
NDAs:9
Suppliers / Packagers: see list1
Bulk Api Vendors: see list35
Clinical Trials: see list12
Patent Applications: see list4,156
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIMENHYDRINATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva
DIMENHYDRINATE
dimenhydrinate
INJECTABLE;INJECTION080615-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
DIMENHYDRINATE
dimenhydrinate
TABLET;ORAL085166-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
DIMENHYDRINATE
dimenhydrinate
INJECTABLE;INJECTION040519-001Jun 23, 2004RXNoYes► Subscribe► Subscribe
Baxter Hlthcare
DIMENHYDRINATE
dimenhydrinate
INJECTABLE;INJECTION084767-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Alra
DIMENHYDRINATE
dimenhydrinate
LIQUID;ORAL080715-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Healthtrust
Daiichi Sankyo
Argus Health
Merck
UBS
Chubb
Farmers Insurance
QuintilesIMS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot